Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Surgical MAchine learning model for predicting Risk of postoperative infecTions in general elective surgery (SMART): A modelling study.

International journal of antimicrobial agents·2026
Same author

P02 A single-centre, retrospective study of paediatric tinea capitis in the United Kingdom.

The British journal of dermatology·2025
Same author

Systematic review to understand users perspectives on AI-enabled decision aids to inform shared decision making.

NPJ digital medicine·2024
Same author

Impact of computerised provider order entry on the quality and quantity of clinical information included with investigation requests: an interrupted time series analysis.

BMJ open quality·2023
Same author

Misspelling of antimicrobials by healthcare professionals.

BMJ (Clinical research ed.)·2022
Same author

Correction to: Pilot study to identify missed opportunities for prevention of childhood tuberculosis.

European journal of pediatrics·2022
Same journal

The Leprosy Post-Exposure Prophylaxis (LPEP) programme: update and interim analysis.

Leprosy review·2023
Same journal

From the new ILA President.

Leprosy review·2018
Same journal

19th International Leprosy Congress: the Plenary Sessions.

Leprosy review·2018
Same journal

Letter to the Editor: Perspective of Sensory Ataxia in Leprosy.

Leprosy review·2018
Same journal

Pseudoathetosis and ataxia – a rare presentation of multibacillary leprosy in a non-endemic area.

Leprosy review·2018
Same journal

Protocol for a Randomised Controlled Trial Investigating Decompression for Leprous Neuropathy (The DELN Protocol).

Leprosy review·2018
See all related articles

Related Experiment Video

Updated: May 14, 2026

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples
08:54

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples

Published on: May 19, 2020

Assessing and improving adherence with multidrug therapy.

Daniel Weiand1, Janine Thoulass, W Cairns S Smith

  • 1Specialty Trainee in Medical Microbiology, York Teaching Hospital NHS Foundation Trust, UK.

Leprosy Review
|January 30, 2013
PubMed
Summary
This summary is machine-generated.

Ensuring adherence to multidrug therapy (MDT) for leprosy is crucial for preventing relapse and drug resistance. Community-based interventions, similar to those used for tuberculosis (TB) and HIV, can improve treatment outcomes and patient adherence.

More Related Videos

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

Related Experiment Videos

Last Updated: May 14, 2026

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples
08:54

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples

Published on: May 19, 2020

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

Area of Science:

  • Infectious Diseases
  • Public Health
  • Pharmacology

Background:

  • Adherence to multidrug therapy (MDT) is critical in leprosy treatment to prevent relapse and drug resistance.
  • Assessing patient adherence to prescribed regimens is essential for effective disease management.

Purpose of the Study:

  • To review methods for assessing adherence to MDT in leprosy.
  • To explore community-based approaches for improving adherence, drawing parallels with tuberculosis (TB) and HIV treatment.

Main Methods:

  • Literature search of MEDLINE for 'leprosy' combined with 'adherence,' 'compliance,' or 'concordance.'
  • Further search for community interventions in HIV, TB, or leprosy adherence support in low and middle-income countries.

Main Results:

  • Routine leprosy programs use defaulting and treatment completion as adherence proxies.
  • Various assessment methods exist, including questionnaires, pill counts, and direct measures; multiple methods enhance accuracy.
  • Community interventions (e.g., treatment observation, counseling, social support) show promise in improving TB and HIV outcomes, applicable to leprosy.

Conclusions:

  • Regular assessment and feedback are vital for leprosy patient adherence.
  • Leprosy programs can benefit from adapting successful adherence interventions from TB and HIV programs.